http://web.archive.org/web/20131226193806id_/http://www.cnn.com/2012/10/29/health/massachusetts-pharmacy-license/index.html

-- a second @entity3 compounding pharmacy surrendered its license after state inspectors found " significant " issues that could affect sterility , state health officials said			1
the pharmacy , @entity10 , was also found to have a center for giving intravenous medications to patients in violation of state regulations , which require a clinic license , dr. @entity8 , director of the @entity9 , said sunday			1
the state @entity17 immediately issued a cease and desist notice to @entity10 after the october 23 inspection revealed the violations , she said			2
over the weekend , the @entity24 " secured the voluntary surrender of @entity10 's pharmacy license			1
" the company , which compounds antibiotic and nutritional iv medications for home use , said in a statement it has since recalled all compounded products dispensed in the past month , effecting 38 patients			1
" no issues were cited related to the integrity of our products nor to the quality of our compounding practices , " said @entity31 , @entity10 ceo , in a statement			1
" it is correct that @entity10 does not have a clinic license from the @entity3			2
the space in our facility is intended for patient education , validation of patient and caregiver skills , medication counseling , medication education , teaching and training			0
" what is a compounding pharmacy ? @entity3 gov. @entity54 said last week the state would immediately begin unannounced inspections of all @entity3 pharmacies and require that they submit annual reports detailing what they produce and distribute			2
that announcement came in the wake of the fungal meningitis outbreak that has caused 25 deaths and 354 illnesses , linked to the @entity3 - based @entity66			1
seven of those illnesses are peripheral joint infections that specifically affect a joint such as a knee , hip , shoulder or elbow			0
infusion resource is not linked to the outbreak			0
the incident began unfolding september 24 , when the department was notified about a cluster of six rare fungal meningitis cases in @entity80			0
the patients shared several risk factors , including having received an epidural injection of a steroid -- methylprednisolone acetate -- that had been compounded at the @entity66 in @entity86			0
the department soon learned that the suspect product had been distributed to more than 14,000 patients in 23 states			0
@entity91 : drug maker had internal warnings months before meningitis outbreak the @entity24 has asked two other companies -- @entity96 and @entity97 -- to cease all pharmacy operations based on their shared ownership and leadership with @entity66			1
" @entity66 's transparency in dealing with the board since inception in 1998 demonstrates its good faith intention to operate in compliance with the requirements of its license , " said @entity101 , a @entity102 - based lawyer representing the compounder , in a statement last week			0
" furthermore , the company 's intention and best efforts at compliance are equally applicable in every other state in which it has been licensed			0

*investigators* found " significant " issues in an inspection of @entity10
the company surrendered its pharmacy license over the weekend
it has recalled all compounded products dispensed in the past month
the inspections are conducted in the wake of a *multistate* meningitis outbreak

@entity3:Massachusetts
@entity17:Board of Pharmacy
@entity0:CNN
@entity24:Department of Public Health
@entity10:Infusion Resource
@entity66:NECC
@entity9:Massachusetts Department of Public Health Bureau of Healthcare Safety and Quality
@entity8:Madeleine Biondolillo
@entity80:Tennessee
@entity101:Paul Cirel
@entity102:Boston
@entity86:Framingham
@entity54:Deval Patrick
@entity97:Alaunus Pharmaceutical
@entity96:Ameridose
@entity31:Bernard Lambrese
@entity91:FDA